Literature DB >> 26476039

C/EBPβ is required in pregnancy-induced cardiac hypertrophy.

I Redondo-Angulo1, A Mas-Stachurska2, M Sitges2, M Giralt1, F Villarroya1, A Planavila3.   

Abstract

AIM: Pregnancy is a physiological model of adaptive and reversible heart enlargement, but the molecular mechanisms determining this kind of physiologic cardiac hypertrophy are poorly known. Here, we analyzed the role of the transcription factor C/EBPβ in the development of pregnancy-induced cardiac hypertrophy.
RESULTS: C/EBPβ+/- mice at day 18 of gestation were used as happloinsufficiency model of late pregnancy. We found that C/EBPβ expression was specifically increased in hearts from Wt pregnant mice whereas expression of other C/EBP subtypes (α and δ) was not affected by gestation. Pregnancy-induced changes in systemic metabolic and hormonal profiles were not essentially different in Wt versus C/EBPβ+/- mice. However, C/EBPβ+/- mice developed pregnancy-induced heart hypertrophy to a lower extent relative to Wt mice. Furthermore, hearts from C/EBPβ+/- mice have alterations in fatty acid oxidation genes and reductions in the expression levels of glucose transporters that may compromise metabolic cardiac function during pregnancy. Among marker genes of inflammation, interleukin-6 (Il-6) showed a marked differential behavior in C/EBPβ+/- pregnant mice: pregnancy strongly induced cardiac Il-6 expression in wt, a phenomenon that did not occur in C/EBPβ+/- mice. Moreover, marker genes for M2 macrophages were decreased in C/EBPβ+/- pregnant mice and in C/EBPβ-/- mice subjected to LPS stimulus.
CONCLUSIONS: Here we found that normal levels of C/EBPβ are required for hypertrophy development during pregnancy. Events such as the increase in IL-6 in the heart of pregnant mice are prevented in C/EBPβ+/- animals. Moreover, C/EBPβ controls M2-macrophage gene expression in the heart. Thus, C/EBPβ appears as a transcription factor required for cardiac hypertrophy response to gestation.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  C/EBPβ; Cardiac hypertrophy; Macrophages; Pregnancy

Mesh:

Substances:

Year:  2015        PMID: 26476039     DOI: 10.1016/j.ijcard.2015.10.005

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  PDK4 Inhibits Cardiac Pyruvate Oxidation in Late Pregnancy.

Authors:  Laura X Liu; Glenn C Rowe; Steven Yang; Jian Li; Federico Damilano; Mun Chun Chan; Wenyun Lu; Cholsoon Jang; Shogo Wada; Michael Morley; Michael Hesse; Bernd K Fleischmann; Joshua D Rabinowitz; Saumya Das; Anthony Rosenzweig; Zoltan Arany
Journal:  Circ Res       Date:  2017-09-19       Impact factor: 17.367

2.  Maternal cardiac messenger RNA expression of extracellular matrix proteins in mice during pregnancy and the postpartum period.

Authors:  Megan E Parrott; Esam Aljrbi; Diane L Biederman; Ryan N Montalvo; Jeremy L Barth; Holly A LaVoie
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

3.  New Molecular Mechanism Underlying Myc-Mediated Cytochrome P450 2E1 Upregulation in Apoptosis and Energy Metabolism in the Myocardium.

Authors:  Feifei Guan; Xinlan Yang; Jing Li; Wei Dong; Xu Zhang; Ning Liu; Shan Gao; Jizheng Wang; Lianfeng Zhang; Dan Lu
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

4.  Meteorin-like/Meteorin-β protects heart against cardiac dysfunction.

Authors:  Celia Rupérez; Gemma Ferrer-Curriu; Aina Cervera-Barea; Laura Florit; Mariona Guitart-Mampel; Gloria Garrabou; Mònica Zamora; Fàtima Crispi; Joaquim Fernandez-Solà; Josep Lupón; Antoni Bayes-Genis; Francesc Villarroya; Anna Planavila
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

5.  Novel rat model of multiple mitochondrial dysfunction syndromes (MMDS) complicated with cardiomyopathy.

Authors:  Yahao Ling; Jiaxin Ma; Xiaolong Qi; Xu Zhang; Qi Kong; Feifei Guan; Wei Dong; Wei Chen; Shan Gao; Xiang Gao; Shuo Pan; Yuanwu Ma; Dan Lu; Lianfeng Zhang
Journal:  Animal Model Exp Med       Date:  2021-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.